AR018622A1 - Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos - Google Patents
Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlosInfo
- Publication number
- AR018622A1 AR018622A1 ARP990102619A ARP990102619A AR018622A1 AR 018622 A1 AR018622 A1 AR 018622A1 AR P990102619 A ARP990102619 A AR P990102619A AR P990102619 A ARP990102619 A AR P990102619A AR 018622 A1 AR018622 A1 AR 018622A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- prepare
- formula
- compounds
- piperid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018622A1 true AR018622A1 (es) | 2001-11-28 |
Family
ID=10833098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102619A AR018622A1 (es) | 1998-06-03 | 1999-06-03 | Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1087964A1 (hr) |
| JP (1) | JP2002517392A (hr) |
| KR (1) | KR20010052526A (hr) |
| CN (1) | CN1304408A (hr) |
| AR (1) | AR018622A1 (hr) |
| AU (1) | AU4369599A (hr) |
| BG (1) | BG104988A (hr) |
| BR (1) | BR9910927A (hr) |
| CA (1) | CA2333756A1 (hr) |
| CO (1) | CO5021190A1 (hr) |
| GB (1) | GB9811879D0 (hr) |
| HR (1) | HRP20010005A2 (hr) |
| HU (1) | HUP0102233A2 (hr) |
| ID (1) | ID27067A (hr) |
| IL (1) | IL139552A0 (hr) |
| NO (1) | NO20006041L (hr) |
| PL (1) | PL344594A1 (hr) |
| SK (1) | SK17602000A3 (hr) |
| TR (1) | TR200003569T2 (hr) |
| WO (1) | WO1999062902A1 (hr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
| WO2001085168A1 (en) * | 2000-05-12 | 2001-11-15 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
| CN1174979C (zh) * | 2000-05-12 | 2004-11-10 | 索尔瓦药物有限公司 | 哌嗪和哌啶化合物 |
| WO2006089053A2 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 CN CN99806908A patent/CN1304408A/zh active Pending
- 1999-05-26 IL IL13955299A patent/IL139552A0/xx unknown
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/ko not_active Application Discontinuation
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Application Discontinuation
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/ja active Pending
- 1999-05-26 PL PL99344594A patent/PL344594A1/xx not_active Application Discontinuation
- 1999-05-26 ID IDW20002519A patent/ID27067A/id unknown
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/hu unknown
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/xx unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/pt not_active IP Right Cessation
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/sk unknown
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-06-03 AR ARP990102619A patent/AR018622A1/es not_active Application Discontinuation
- 1999-06-03 CO CO99035020A patent/CO5021190A1/es unknown
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/bg unknown
- 2000-11-29 NO NO20006041A patent/NO20006041L/no not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG104988A (bg) | 2001-11-30 |
| AU4369599A (en) | 1999-12-20 |
| GB9811879D0 (en) | 1998-07-29 |
| NO20006041D0 (no) | 2000-11-29 |
| HUP0102233A2 (hu) | 2002-05-29 |
| TR200003569T2 (tr) | 2001-04-20 |
| CO5021190A1 (es) | 2001-03-27 |
| ID27067A (id) | 2001-02-22 |
| SK17602000A3 (sk) | 2001-08-06 |
| KR20010052526A (ko) | 2001-06-25 |
| EP1087964A1 (en) | 2001-04-04 |
| JP2002517392A (ja) | 2002-06-18 |
| HRP20010005A2 (en) | 2001-12-31 |
| CA2333756A1 (en) | 1999-12-09 |
| IL139552A0 (en) | 2002-02-10 |
| NO20006041L (no) | 2000-11-29 |
| WO1999062902A1 (en) | 1999-12-09 |
| CN1304408A (zh) | 2001-07-18 |
| BR9910927A (pt) | 2001-02-20 |
| PL344594A1 (en) | 2001-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60126344T2 (de) | Isoindolimid-verbindungen, zusammensetzungen und verwendungen | |
| DE69622532T2 (de) | Glycoprotein iib/iiia-antagonisten | |
| WO2012046030A2 (en) | Phosphodiesterase inhibitors | |
| CA2596355A1 (en) | Tumor necrosis factor inhibitors | |
| JPS5995269A (ja) | 抗てんかん性医薬品 | |
| FR2899586A1 (fr) | Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique | |
| CN1094936C (zh) | 新黄酮化合物、制备它们的方法以及含有它们的药物组合物 | |
| US20190084909A1 (en) | Fluorinated cbd compounds, compositions and uses thereof | |
| Varró et al. | The First Enantioselective Total Synthesis of (−)-trans-Dihydronarciclasine | |
| CN103097355A (zh) | 用于治疗皮肤病的新的喹啉酯 | |
| CN100586937C (zh) | 川芎嗪茋类衍生物、制备方法和药物组合物与应用 | |
| Augstein et al. | Relation between antihistamine and antidepressant activity in hexahydroindenopyridines | |
| AR064134A1 (es) | Derivados de 2-aminoquinolina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo de los receptores 5-ht5a. | |
| Augstein et al. | Adrenergic neurone blocking agents derived from 1, 4-benzodioxan | |
| Modi et al. | Potential anticancer agents. III. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles | |
| JPH04500362A (ja) | 新規な８―置換―２―アミノテトラリン類 | |
| AR018622A1 (es) | Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos | |
| EP2032561A2 (fr) | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques | |
| DE4341402A1 (de) | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung | |
| JPS5980668A (ja) | Ｎ−アリル化オキサゾリジン−２−オンの光学活性な誘導体、該誘導体の製法及び該誘導体による薬剤 | |
| JPH07505120A (ja) | チアフィゾベニンのカルバミン酸類縁化合物、医薬品用組成物、ならびにコリンエステラーゼ阻害方法 | |
| US4260762A (en) | Octahydro-1H-pyrrolo[2,3-g]isoquinolines | |
| US20040039023A1 (en) | Therapeutic agents | |
| Mansoor et al. | Silica-bonded N-propylpiperazine sodium n-propionate as an efficient recyclable catalyst for one-pot synthesis of 2-amino-4-aryl-4 H, 8 H-6-methyl-8-oxo-pyrano [3, 2-b] pyran derivatives | |
| US4201783A (en) | Antidepressant substituted hexahydro benzopyrano [3,2-c] pyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |